Field research on large mammals has been greatly facilitated by the development of chemical restraint techniques. However, species differ in their responses to particular drugs and no single drug works well on all species. In field work, the investigator usually desires a drug that is absorbed rapidly after intramuscular injection, provides adequate restraint with a minimum of troublesome side effects, and has a wide margin of safety. In addition, the drug's effects should be reasonably predictable and permit a quick recovery, and the drug itself should be chemically stable over a wide range of temperatures.
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Succinylcholine chloride (Anectine, Burroughs Welcome; Sucostrin, Squibb) has been used alone or in combination with a barbiturate anesthetic in several studies applying chemical restraint to bears (Erickson 1957 , Black 1958 , Craigheadetal. 1960 The weight of each bear was estimated visually and, after the first few trials, CI-744 dosage was routinely calculated at 4.4 mg/kg. A syringe mounted on the end of a pole was used to inject the drug into the rump, thigh, or shoulder musculature. After a bear was immobilized, it was weighed on a spring scale, measured, tagged, and given a prophylactic dose (5 ml/50 kg) of long-acting antibiotic (Bicillin, Wyeth). Rectal temperature and heart and breathing rates were recorded during most immobilization episodes, usually within 30 minutes of achieving restraint, but no attempt was made to monitor these parameters at regular intervals. The age of each bear was initially estimated on the basis of tooth wear and was later checked in most individuals by counting cementum layers (Stoneberg and Jonkel 1966, Willey 1974) around the root of a third premolar tooth.
CI-744 was evaluated primarily in terms of the following parameters: induction time, from injection to loss of head-lifting response when mechanically stimulated; restraint time, from loss of head-lifting response to beginning of head-lifting response; emergence time, from first head-lifting response to standing position; total down time, from loss of head-lifting response to standing (restraint time plus emergence time); dosage rate, mg/kg needed to produce restraint. Data on these parameters were obtained for each episode of immobilization. However, the tabular data presented here pertain only to those 25 episodes for which complete and accurate records were obtained after single injections. Mean values for immature (1-3 years old) and adult (4+ years old) bears were compared statistically using the Student's t-test.
RESULTS
A total of 39 different bears, all judged to be in good health, were immobilized in the field with CI-744 between August 1974 and November 1976. Ten immature (9 male, 1 female) and 12 adult (all male) bears provided the 25 immobilization episodes for our data on time parameters and dosage rates. The immature female and 2 adult males contributed 2 episodes each. Twenty of the 25 episodes reported occurred in the months MayOctober, and 5 occurred in November-December.
Estimated weights of the bears tended to be slightly lower than the true weights. As a result, the average dosage rate was 4.1 mg/kg. Mean dosage rates for immature and adult bears were not significantly different (P > 0.05). However, mean induction, restraint, and total down times all were significantly (P < 0.05) shorter for immature than for adult bears, whereas mean emergence times were nearly identical (Table 1) .
Scatter diagrams and regression equations were prepared to obtain estimates of how closely induction, restraint, and emergence times were correlated with dosage rate and body weight. Data points were widely scattered in each case and only the following positive correlations were statistically significant: restraint time/dosage rate (Y = 34.9X -63.6, r = +0.44, P < 0.05); emergence time/dosage rate (Y = 14.6X -24.5, r = +0.49, P < 0.05); restraint time/body weight (Y = 0.44X + 21.9, r = +0.53, P < 0.01).
Eight immature (7 male, 1 female) and 22 adult (20 male, 2 female) bears provided 37 episodes in which rectal temperature and heart and breathing rates all were recorded 1 or more times during the restraint period. Means for these parameters in the immature and adult bears were not significantly different (P > 0.05). Means, standard errors, and ranges derived from the pooled observations (N = 49) were: rectal temperature, 38.1 ? 0.1 C (36.9 -39.2); heart rate, 113 ? 16 
DISCUSSION
Explanations for the observed differences (or lack of them) between immature and adult bears, with respect to the time parameters studied, are largely speculative. Although variability in our data and in those of other investigators is great, some trends are evident. Young, lightweight polar bears (Ursus maritimus) (Larsen 1971 ) and other mammals (Seal and Erickson 1969) have been observed to require higher dosage rates of Semylan than adults to achieve restraint and have been noted to recover more quickly. Larsen (1971) attributed the higher dosage rates and quicker recovery to the higher metabolic rate of younger bears. The shorter mean induction and restraint times observed in the younger bears injected with CI-744 also might be due in part to higher metabolic rates. However, a factor of major importance may be the amount of body fat in the individual animal. Fat may account for a greater percentage of body weight in older, heavier bears and may serve as a nonmetabolic reservoir for the drug, thereby increasing both the time required for the drug to reach effective levels in the brain and the time required for its elimination from the body. Unfortunately, we do not have sufficient data to compare bears in specific ageclasses at different seasons and to analyze the effects of increasing fat deposits. Since some tiletamine may be excreted without being metabolized (F. Eads, WarnerLambert/Parke-Davis and Company, personal communication), another consideration is that any impairment of kidney function that might occur in older bears would also increase excretion and restraint times.
The lack of a statistically significant difference between the mean emergence times of immature and adult bears may be an artifact of our small sample size and the relatively imprecise end point of emergence. We therefore refrain from speculating on any pharmacodynamic implications. However, the observation that restraint and emergence times increased with dosage rate seems explicable on the basis that the drug was metabolized and/or excreted at a constant rate by the animal. If so, larger doses required a longer time to be eliminated from the body, and restraint and emergence times were prolonged.
The observable sequence of effects of CI-744 was similar to that described for Semylan by Pearson et al. No convulsions occurred in bears immobilized with CI-744. Heat stress was minimized by working in the shade during daylight hours, and ambient temperatures for our series of immobilization episodes ranged from 4 to 28 C. There was considerable variation in rectal temperatures and in heart and breathing rates. Although some of this variation might have been due to different dosage rates or to the circumstances of immobilization and handling, the available data are not sufficient to demonstrate consistent relationships. The rectal temperatures of bears immobilized with CI-744 were virtually the same as those Hock (1957 Hock ( , 1960 reported for nonhibemating, unanesthetized bears. Heart rates were notably higher than those reported for sleeping bears in summer (Folk 1967 , Folk et al. 1972 ) and were comparable to those of bears in "a very active state" (Folk 1967:76) . This tachycardia may have been due to the influence of tiletamine on cardiovascular regulatory centers in the brain (Chen et al. 1969). We are not aware of any published data on breathing rates in resting bears, but Chen et al. (1969) found that tiletamine did not cause respiratory depression in monkeys at anesthetic dosages, which is probably true for bears also. In our experience, the effects of CI-744 on rectal temperature and on heart and breathing rates are similar to the effects of Sernylan and Promazine in combination.
The optimum dosage rate of CI-744 for routine field work with adult black bears appears to be about 4.0 mg/kg. Younger bears may require 4.4 mg/kg to provide adequate restraint. As a matter of procedure, this latter dosage rate is probably the best for routine use because some degree of control will be achieved with a good injection even if the weight of the bear is slightly underestimated. CI-744 has at least a 3-fold safety margin, as In Summary, we find that the advantages of CI-744 compared with the Semylan-promazine combination are (1) shorter emergence and restraint times; (2) less salivary and respiratory secretion; and (3) greater ease of use, because two drugs do not have to be mixed and supplemental drugs (such as atropine) are not needed.
Aqueous solutions of CI-744, freshly prepared at a concentration of 300 mg/ml, are pale yellowish brown. We have noted some darkening with age, though potency does not seem to have been affected. Refrigeration probably should be used to maintain long-term potency.
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